Fei Yu

机构：Yunnan Academy of Agricultural Sciences · ORCID：0000-0003-1546-9365

发表论文 132 篇 · 总被引 7202 次 · h-index 36

代表论文

• Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges (2025 · Molecular Cancer · 被引 92)
• Programmed cell death in tumor immunity: mechanistic insights and clinical implications (2024 · Frontiers in Immunology · 被引 40)
• Development of a PCSK9-targeted nanoparticle vaccine to effectively decrease the hypercholesterolemia (2024 · Cell Reports Medicine · 被引 25)
• ICOS-expressing CAR-T cells mediate durable eradication of triple-negative breast cancer and metastasis (2024 · Journal for ImmunoTherapy of Cancer · 被引 11)
• The histamine receptor H1 acts as an alternative receptor for SARS-CoV-2 (2024 · mBio · 被引 11)
• Specific loading of oncolytic VSV on CAR enhances CAR-T cell signaling and antitumor activity (2025 · The Journal of Experimental Medicine · 被引 7)